DROPIZOL

This brand name is authorized in Austria, Finland, Ireland, Netherlands, Romania, UK.

Active ingredients

The drug DROPIZOL contains one active pharmaceutical ingredient (API):

1	Opium UNII 37M3MZ001L - OPIUM
	Opium alkaloids (opioids and isoquinoline derivatives) induce constipation, euphoria, analgesia and sedation dependent on the dose and derivative. The constipating effect is caused by inhibition of the intestines' peristalsis.
	Read more about Opium

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DROPIZOL Oral drops, solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07DA02	Opium	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FI	Lääkealan turvallisuus- ja kehittämiskeskus	044780, 480553
GB	Medicines & Healthcare Products Regulatory Agency	371230
NL	Z-Index G-Standaard, PRK	202037
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68999001, W68999002, W68999003, W68999004, W68999005, W68999006